Newsroom

In some territories, which are listed in our website footer, our microsampling devices are supplied for therapeutic or IVD use as referenced in some of our content. Outside of those territories our devices are supplied for research use only (RUO).

Neoteryx Founder Fasha Mahjoor Receives Science History Institute's Pittcon Award

by Neoteryx, on October 13,2021

Neoteryx Founder Fasha Mahjoor Receives Science History Institute's Pittcon Award

October 2021 — The Science History Institute (the Institute) has announced Fasha Mahjoor as the recipient of the 21st annual Pittcon Heritage Award. Mahjoor is the founder and CEO of …

Read Story

Neoteryx's Mitra Devices for Specimen Collection Registered in S. Africa

by Neoteryx, on October 4,2021

Neoteryx's Mitra Devices for Specimen Collection Registered in S. Africa

ZA Approval of Mitra® Devices for Remote Specimen Collection at Home Gives Citizens Living in Rural Areas Greater Access to Critical Lab Services Los Angeles, USA & South Africa — …

Read Story

COVID-19 Spurred Mitra Microsampling Innovation in Bioanalysis

by Neoteryx, on September 23,2021

COVID-19 Spurred Mitra Microsampling Innovation in Bioanalysis

September 2021 — According to a preprint article slated for publication in the next issue of the journal Bioanalysis, the COVID-19 pandemic led to a shift in the way blood …

Read Story

Neoteryx's Mitra Devices Now IVD Registered in China

by Neoteryx, on August 18,2021

Neoteryx's Mitra Devices Now IVD Registered in China

Los Angeles, USA & Beijing, CHINA — The Mitra® microsampling device from US-based Neoteryx is now registered as a Class I in vitro diagnostic (IVD) medical device with the Chinese …

Read Story

Dried Blood Analysis Being Trialed in Tokyo for Anti-Doping

by Neoteryx, on August 3,2021

Dried Blood Analysis Being Trialed in Tokyo for Anti-Doping

AUGUST 2021 — According to a news item from Peit Kreuzer reporting in Germany for Deutschlandfunk, doping in sports is dominating the headlines as global sports agencies consider new and …

Read Story
Prev All Posts Next

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs
Neoteryx Experts

Media Contacts
Media Assets
Scientific Research Publications

social media

subscribe to news

Fuel Your Innovative Approach to Science & Research. Subscribe to Our Microsampling Newsletter!

Get Our Newsletter

 

Get in Touch

 

Neoteryx, LLC

© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501

This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.

part-of-trajan-family-logo-white-text

 

Get To Know Us

Follow Us

Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC. 

hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.  

Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.